Central Alabama Radiation Oncology delivers treatment using the most sophisticated and modern technology of its kind in Alabama. State-of-the-art machinery combined with advanced computer technology and specialized software help ensure the best results.


Radiation therapy is delivered using Varian Medical Systems’ TrueBeamT™ and Clinac® 21IX linear accelerators. The TrueBeamT™ provides advanced imaging and motion management technologies that target tumors with pinpoint accuracy allowing shorter treatment times. Many types of cancer, including complex cases where a tumor is located in the lungs, breast, liver, abdomen, head or neck are treated with this machine. The Clinac® 21IX delivers exact doses to the patient in the lowest number of monitor units without sacrificing efficacy. Other innovative features include the highest resolution multileaf collimator to treat even the smallest lesions and technically precise beam control for minuscule accuracy in radiation delivery. Some of our technologies include:


Radiation therapy applies high levels of radiation to kill cancer cells or keep them from growing and dividing while minimizing damage to healthy cells. Radiation therapy is delivered in many different ways depending upon the type of cancer and the stage of treatment. The following are the types of radiation treatment we provide:

EBRT or External Beam Radiation Therapy

EBRT or External Beam Radiation Therapy uses machines known as linear accelerators to beam radiation which delivers dosage deep onto the area of the body where the cancer is located. The use of EBRT machines has significantly reduced side effects and modern state-of-the-art equipment has vastly improved the ability to deliver radiation. EBRT is usually given for approximately 6 to 8 weeks on an outpatient basis.

3D-CRT or Three-Dimensional Conformal Radiation Therapy

3D-CRT or Three-Dimensional Conformal Radiation Therapy is a method for delivering EBRT more precisely by using a special CT scan and computerized model. 3D-CRT promises to reduce the damage to tissues near the cancer. 3D-CRT is being tested to determine if higher doses can be given safely with higher outcomes.

IMRT or Intensity Modulated Radiation Therapy

IMRT or Intensity Modulated Radiation Therapy allows radiation oncologists to customize dose varying the amount of radiation given to different parts of the area being treated. It is an advanced form of 3-D conformal radiation therapy. Computer-controlled moveable “leaves” adjust the radiation intensity so that more radiation can be delivered to the tumor while normal cells nearby receive less.

IGRT of Image-Guided Radiation Therapy

IGRT of Image-Guided Radiation Therapy involves imaging during the course of treatment allowing more accurate delivery of radiation. Images taken during the planning phase of treatment are compared to images taken during treatment. Sometimes the location of the cancer may shift in a patient’s body and this treatment allows better accuracy of the radiation delivery. IGRT is often used along with EBRT, 3D-CRT or IMRT.


Brachytherapy is internal radiation, sometimes referred to as “seeds” or “implants.” In brachytherapy, radioactive material is placed directly into or near the cancer. Brachytherapy may be used alone or along with external beam radiation therapy. The seeds or implants may be permanent or temporary. Brachytherapy has been effective in the treatment of several types of cancer such as prostate, cervix, uterus, vagina, head and neck and breast.

Breast Brachytherapy

Women with breast cancer who choose breast conservation rather than a mastectomy may benefit from Breast Brachytherapy. After the removal of the tumor in a process called a lumpectomy, radiation may be administered using traditional EBRT which typically takes 5 to 6 weeks of treatment. Sometimes it is possible to reduce this treatment time down to as little as 2 to 3 days by using breast brachytherapy. Because of its short duration, women who do not wish to undergo 6 to 8 weeks of EBRT in breast conservation treatment find this an attractive option.

SRS or Stereotactic Radiosurgery

SRS or Stereotactic Radiosurgery is delivered on an outpatient basis and delivers a high dose of radiation to a highly defined target. It is a non-invasive procedure used for the treatment of brain tumors, arteriovenous malformation, and other conditions.


Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM). Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery, and completion of radiation therapy together with concomitant standard of care chemotherapy.

Optune Lua

Optune Lua is approved for the first-line treatment of adult patients with unresectable, locally advanced or metastatic, MPM to be used concurrently with pemetrexed and platinum-based chemotherapy. In a clinical study, MPM patients treated with Optune Lua plus chemotherapy experienced a median overall survival of 18.2 months.

SpaceOAR Hydrogel

SpaceOAR Hydrogel is clinically shown to minimize urinary, sexual, bowel side effects and protect quality of life for prostate cancer patients undergoing radiation therapy.